78.50USD+2.37%Mkt Cap: 3.57B $P/E: 38.291d ago
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collectio…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap3.57B $
Enterprise Value4.60B $
Revenue (TTM)1.33B $
Gross Profit787.59M $
Net Income (TTM)97.31M $
Revenue/Share28.28 USD
Last Price78.50 USD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees3.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)38.29
P/E (Forward)13.95
PEG1.19
EV/EBITDA12.87
EV/Revenue3.45
P/S2.67
P/B4.46
EPS (TTM)2.05
EPS (Forward)5.63
52W Range
47.3278% of range87.32
52W High87.32 USD
52W Low47.32 USD
Profitability
Gross Margin59.04%
Oper. Margin13.88%
EBITDA Margin26.77%
Profit Margin7.29%
ROE12.22%
ROA4.06%
Growth
Revenue Growth4.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF293.22M $
CapEx (TTM)32.78M $
FCF Margin22.35%
FCF Yield8.36%
Net Debt1.03B $
Net Debt/EBITDA2.88
Balance Sheet
Debt/Equity1.54
Current Ratio2.95
Quick Ratio1.64
Book Value/Sh17.60 USD
Cash/Share5.419 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateDec 3, 2012
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)86.60 USD
Upside (mean)+10.3%
Target Range62.00 USD – 104.00 USD
$62.00+10.3% to mean$104.00
# Analysts10
Ownership
Shares Out.45.45M
Float44.86M
Insiders1.22%
Institutions109.55%
Short Interest
Short Ratio2.8d
Short % Float8.70%
Short % Out.6.41%
Shares Short2.91M
Short (prev mo.)2.96M
Technical
SMA 5068.96 (+13.8%)
SMA 20065.92 (+19.1%)
Beta0.52
S&P 52W Chg19.63%
Avg Vol (30d)711.39K
Avg Vol (10d)672.31K
Technical Indicators
RSI (14)63.1
MACD1.7275
MACD Signal1.9132
MACD Hist.-0.1857
BB Upper78.48 USD
BB Middle75.07 USD
BB Lower71.66 USD
BB Width9.09%
ATR (14)2.822 USD
Vol Ratio (20d)1.41x